Cargando…
Discovery of the first dual GSK3β inhibitor/Nrf2 inducer. A new multitarget therapeutic strategy for Alzheimer’s disease
The formation of neurofibrillary tangles (NFTs), oxidative stress and neuroinflammation have emerged as key targets for the treatment of Alzheimer’s disease (AD), the most prevalent neurodegenerative disorder. These pathological hallmarks are closely related to the over-activity of the enzyme GSK3β...
Autores principales: | Gameiro, Isabel, Michalska, Patrycja, Tenti, Giammarco, Cores, Ángel, Buendia, Izaskun, Rojo, Ana I., Georgakopoulos, Nikolaos D., Hernández-Guijo, Jesús M., Teresa Ramos, María, Wells, Geoffrey, López, Manuela G., Cuadrado, Antonio, Menéndez, J. Carlos, León, Rafael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374710/ https://www.ncbi.nlm.nih.gov/pubmed/28361919 http://dx.doi.org/10.1038/srep45701 |
Ejemplares similares
-
Antioxidant, Anti-inflammatory and Neuroprotective Profiles of Novel 1,4-Dihydropyridine Derivatives for the Treatment of Alzheimer’s Disease
por: Michalska, Patrycja, et al.
Publicado: (2020) -
Deficiency in the transcription factor NRF2 worsens inflammatory parameters in a mouse model with combined tauopathy and amyloidopathy
por: Rojo, Ana I., et al.
Publicado: (2018) -
Bisavenathramide Analogues as Nrf2 Inductors and Neuroprotectors in In Vitro Models of Oxidative Stress and Hyperphosphorylation
por: Cores, Ángel, et al.
Publicado: (2021) -
Novel Series of Dual NRF2 Inducers and Selective MAO-B Inhibitors for the Treatment of Parkinson’s Disease
por: Duarte, Pablo, et al.
Publicado: (2022) -
Multitarget Drug Discovery
for Tuberculosis and Other
Infectious Diseases
por: Li, Kai, et al.
Publicado: (2014)